Table of Contents - Whitepaper - Strategies to Innovate the Production of Next Generation Bioconjugates

1. Pre-clinical ChallengesThis section of the whitepaper covers Antibody, Site, Linker & Payload combinations to optimize ADCs.
2. Improved Targeting for Solid TumorsIn this section of the whitepaper you will read about bispecific ADCs and strategies to improve the therapeutic window.
3. Novel Payloads and Delivery VehiclesThis section covers antibody fragment–drug, centyrin, peptide drug and oligonucleotide conjugates.